What is the recommended treatment for herpes zoster?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Herpes Zoster

For uncomplicated herpes zoster, initiate oral valacyclovir 1 gram three times daily for 7 days, starting within 72 hours of rash onset when possible. 1

First-Line Antiviral Therapy for Uncomplicated Disease

  • Valacyclovir 1 gram orally three times daily for 7 days is the preferred first-line treatment for uncomplicated herpes zoster in immunocompetent patients 1

  • Alternative oral regimens include:

    • Acyclovir 800 mg orally five times daily for 7 days 1
    • Famciclovir 500 mg every 8 hours for 7 days 2
  • Treatment must be initiated within 72 hours of rash onset to maximize effectiveness in reducing severity, duration of eruption, and acute pain intensity 1, 3

  • Delayed initiation beyond 72 hours significantly reduces treatment effectiveness 1

  • Valacyclovir and famciclovir offer superior bioavailability and more convenient dosing schedules compared to acyclovir's five-times-daily regimen, potentially improving adherence 1, 2

Treatment Duration and Endpoints

  • Continue antiviral therapy until all lesions have scabbed, not based on arbitrary calendar days 4

  • The standard minimum duration is 7-10 days, but treatment should be extended if new lesions continue to form or healing remains incomplete 1, 4

  • Complete scabbing of all lesions is the key clinical endpoint that determines when to stop therapy 4

Severe or Disseminated Disease

  • For disseminated, multi-dermatomal, ophthalmic, visceral, or complicated herpes zoster, use intravenous acyclovir 5-10 mg/kg every 8 hours 1

  • Continue IV therapy until clinical improvement occurs, then switch to oral therapy to complete the treatment course 1

  • Treatment must continue for a minimum of 7-10 days and until clinical resolution is attained 1

  • Monitor renal function closely during IV acyclovir therapy with dose adjustments for renal impairment 4

Management in Immunocompromised Patients

  • All immunocompromised patients with herpes zoster require antiviral treatment regardless of timing or duration since rash onset 1

  • Consider temporarily discontinuing or reducing immunosuppressive therapy in severe cases of disseminated VZV infection 1, 4

  • Immunosuppression may be restarted after the patient has commenced anti-VZV therapy and skin vesicles have resolved 1

  • Monitor closely for dissemination and visceral complications throughout treatment 1

  • Consider longer treatment duration if healing is delayed 1

Special Situations

Ramsay Hunt Syndrome (Herpes Zoster Oticus)

  • Initiate valacyclovir 1 gram orally three times daily for 7 days combined with systemic corticosteroids as soon as possible, ideally within 72 hours 5

  • Systemic corticosteroids should be added given facial nerve involvement to potentially improve nerve recovery outcomes 5

  • Do not delay treatment waiting for laboratory confirmation—diagnosis is clinical and treatment must begin immediately 5

HIV-Infected Patients

  • For recurrent orolabial or genital herpes in HIV-infected patients, use famciclovir 500 mg twice daily for 7 days 2

Acyclovir-Resistant Cases

  • For suspected acyclovir-resistant herpes zoster, use foscarnet 40 mg/kg IV every 8 hours 1

  • Acyclovir-resistant isolates are routinely resistant to ganciclovir as well 1

Renal Dose Adjustments

  • For patients with creatinine clearance 40-59 mL/min: famciclovir 500 mg every 12 hours 2

  • For creatinine clearance 20-39 mL/min: famciclovir 500 mg every 24 hours 2

  • For creatinine clearance <20 mL/min: famciclovir 250 mg every 24 hours 2

  • For hemodialysis patients: famciclovir 250 mg following each dialysis 2

Critical Pitfalls to Avoid

  • Never use topical antiviral therapy as it is substantially less effective than systemic therapy 4, 5

  • Do not wait for laboratory confirmation to initiate treatment in typical presentations 5

  • Do not confuse herpes zoster with other conditions—the presence of dermatomal vesicular rash with pain is diagnostic 5

  • Antiviral medications do not eradicate latent virus but control symptoms and reduce complications 4

Infection Control

  • Patients with shingles must avoid contact with susceptible individuals (those who have not had chickenpox) until all lesions have crusted 4

  • Viral shedding peaks in the first 24 hours after lesion onset when most lesions are vesicular 4

Prevention for Future Episodes

  • The recombinant zoster vaccine (Shingrix) is recommended for all adults aged 50 years and older regardless of prior herpes zoster episodes 1, 4

  • Vaccination should ideally occur before initiating immunosuppressive therapies 4

References

Guideline

Treatment of Herpes Zoster

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Herpes zoster guideline of the German Dermatology Society (DDG).

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2003

Guideline

Management of Herpes Zoster

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Herpes Zoster in the Ear (Ramsay Hunt Syndrome)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.